NanoViricides Balance Sheet Health

Financial Health criteria checks 4/6

NanoViricides has a total shareholder equity of $10.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $11.7M and $1.6M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$3.87m
EquityUS$10.11m
Total liabilitiesUS$1.63m
Total assetsUS$11.74m

Recent financial health updates

We Think NanoViricides (NYSEMKT:NNVC) Can Afford To Drive Business Growth

Feb 18
We Think NanoViricides (NYSEMKT:NNVC) Can Afford To Drive Business Growth

Recent updates

We Think NanoViricides (NYSEMKT:NNVC) Can Afford To Drive Business Growth

Feb 18
We Think NanoViricides (NYSEMKT:NNVC) Can Afford To Drive Business Growth

Financial Position Analysis

Short Term Liabilities: NNVC's short term assets ($4.0M) exceed its short term liabilities ($1.6M).

Long Term Liabilities: NNVC has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: NNVC is debt free.

Reducing Debt: NNVC had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NNVC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: NNVC has less than a year of cash runway if free cash flow continues to grow at historical rates of 3.5% each year.


Discover healthy companies